364 related articles for article (PubMed ID: 35994816)
1. Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?
Omidian N; Mohammadi P; Sadeghalvad M; Mohammadi-Motlagh HR
Biomed Pharmacother; 2022 Oct; 154():113534. PubMed ID: 35994816
[TBL] [Abstract][Full Text] [Related]
2. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection.
Alquisiras-Burgos I; Peralta-Arrieta I; Alonso-Palomares LA; Zacapala-Gómez AE; Salmerón-Bárcenas EG; Aguilera P
Mol Neurobiol; 2021 Feb; 58(2):520-535. PubMed ID: 32978729
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway.
Yamada S; Hashita T; Yanagida S; Sato H; Yasuhiko Y; Okabe K; Noda T; Nishida M; Matsunaga T; Kanda Y
Fluids Barriers CNS; 2024 Apr; 21(1):32. PubMed ID: 38584257
[TBL] [Abstract][Full Text] [Related]
4. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human plasma gelsolin reverses increased permeability of the blood-brain barrier induced by the spike protein of the SARS-CoV-2 virus.
Suprewicz Ł; Tran KA; Piktel E; Fiedoruk K; Janmey PA; Galie PA; Bucki R
J Neuroinflammation; 2022 Nov; 19(1):282. PubMed ID: 36434734
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.
Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y
Front Immunol; 2021; 12():697329. PubMed ID: 34386007
[TBL] [Abstract][Full Text] [Related]
7. Interactions of SARS-CoV-2 with the Blood-Brain Barrier.
Erickson MA; Rhea EM; Knopp RC; Banks WA
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800954
[TBL] [Abstract][Full Text] [Related]
8. Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19.
Adesse D; Gladulich L; Alvarez-Rosa L; Siqueira M; Marcos AC; Heider M; Motta CS; Torices S; Toborek M; Stipursky J
Fluids Barriers CNS; 2022 Aug; 19(1):63. PubMed ID: 35982454
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
Achar A; Ghosh C
Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 productively infects human brain microvascular endothelial cells.
Yang RC; Huang K; Zhang HP; Li L; Zhang YF; Tan C; Chen HC; Jin ML; Wang XR
J Neuroinflammation; 2022 Jun; 19(1):149. PubMed ID: 35705998
[TBL] [Abstract][Full Text] [Related]
11. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients.
Veleri S
Exp Brain Res; 2022 Jan; 240(1):9-25. PubMed ID: 34694467
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice.
Qiao H; Deng X; Qiu L; Qu Y; Chiu Y; Chen F; Xia S; Muenzel C; Ge T; Zhang Z; Song P; Bonnin A; Zhao Z; Yuan W
J Med Virol; 2024 May; 96(5):e29671. PubMed ID: 38747003
[TBL] [Abstract][Full Text] [Related]
13. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.
Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL
Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375
[TBL] [Abstract][Full Text] [Related]
14. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
Alam SB; Willows S; Kulka M; Sandhu JK
Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
[TBL] [Abstract][Full Text] [Related]
15. Shared Inflammatory Pathology of Stroke and COVID-19.
Sánchez KE; Rosenberg GA
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563537
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions.
Proust A; Queval CJ; Harvey R; Adams L; Bennett M; Wilkinson RJ
J Neuroinflammation; 2023 Aug; 20(1):184. PubMed ID: 37537664
[TBL] [Abstract][Full Text] [Related]
17. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
18. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
Zhou Z; Kang H; Li S; Zhao X
J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
[TBL] [Abstract][Full Text] [Related]
19. Neurological infection and complications of SARS-CoV-2: A review.
Singh S; Meher N; Mohammed A; Razab MKAA; Bhaskar LVKS; Nawi NM
Medicine (Baltimore); 2023 Feb; 102(5):e30284. PubMed ID: 36749239
[TBL] [Abstract][Full Text] [Related]
20. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER
Front Immunol; 2022; 13():1070379. PubMed ID: 36591311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
